<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The B-cell receptor (BCR) transmits life and <z:hpo ids='HP_0011420'>death</z:hpo> signals throughout B-cell development, and altered BCR signaling may be required for survival of B-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="1" pm="."><plain>We used single-cell signaling profiles to compare follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) B cells and nonmalignant host B cells within individual patient biopsies and identified BCR-mediated signaling events specific to <z:hpo ids='HP_0002665'>lymphoma</z:hpo> B cells </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of CD20, Bcl-2, and BCR light chain isotype (kappa or lambda) distinguished FL <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> B-cell and nontumor host B-cell subsets within FL patient biopsies </plain></SENT>
<SENT sid="3" pm="."><plain>BCR-mediated signaling via phosphorylation of Btk, Syk, Erk1/2, and p38 occurred more rapidly in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> B cells from FL samples than in infiltrating nontumor B cells, achieved greater levels of per-cell signaling, and sustained this level of signaling for hours longer than nontumor B cells </plain></SENT>
<SENT sid="4" pm="."><plain>The timing and magnitude of BCR-mediated signaling in nontumor B cells within an FL sample instead resembled that observed in mature B cells from the peripheral blood of healthy subjects </plain></SENT>
<SENT sid="5" pm="."><plain>BCR signaling pathways that are potentiated specifically in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells should provide new targets for therapeutic attention </plain></SENT>
</text></document>